Doctors and the drug industry: How can we handle potential conflicts of interest?

American Journal of Medicine

Volumn 118, Issue 2, 2005, Pages 99-100

  Alpert, Joseph S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC ASPECT; EDITORIAL; HUMAN; MEDICAL ETHICS; MEDICAL PROFESSION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 13444256068     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.12.003     Document Type: Editorial

References (21)

1. K. Morin, H. Rakatansky, F.A. Riddick Jr Managing conflicts of interest in the conduct of clinical trials JAMA 287 2002 78 84
2. D. Korn Conflicts of interest in biomedical research JAMA 284 2000 2234 2238
3. T.R. Cech, J.S. Leonard Conflicts of interest-moving beyond disclosure Science 291 2001 989
4. B. Lo, L.E. Wolf, A. Berkeley Conflict of interest policies for investigators in clinical trials N Eng J Med 343 2000 1616 1620
5. J. La Puma Physicians' conflict of interest in post-marketing research: What the public should know, and why industry should tell them. Chapter in Research Ethics and Human Subjects: Facing the 21st Century 1995 University Publishing Group Frederick, MD
6. D.D. Federman, K.E. Hanna, L.L. Rodriguez Responsible Research-A Systems Approach to Protecting Research Participants 2003 The National Academies Press Washington, DC
7. N.G. Levinsky Non financial conflicts of interest in research N Engl J Med 347 2002 759 761
8. Committee on Assessing the System for Protecting Human Research Subjects Preserving Public Trust Accreditation and Human Research Participant Protection Programs 2001 National Academy Press Washington, DC
9. J.S. Alpert, S. Furman, L. Smaha Conflicts of interest Arch Intern Med 162 2002 635 637
10. D. Blumenthal Doctors and drug companies N Engl J Med 351 2004 1885 1890
11. D.M. Studdert, M.M. Mello, T.A. Brennan Financial conflicts of interest in physicians' relationship with the pharmaceutical industry-Self regulation in the shadow of federal prosecution N Engl J Med 351 2004 1891 1900
12. A. Wazana Physicians and the pharmaceutical industry Is a gift ever just a gift? JAMA 283 2000 373 380
13. S.M. Keim, M.Z. Mays, D. Grant Interactions between emergency medicine programs and the pharmaceutical industry Acad Emerg Med 11 2004 19 26
14. P.A. Komesaroff, I.H. Kerridge Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry Med J Aust 176 2002 118 121
15. M. Chren Interactions between physicians and drug company representatives Am J Med 107 1999 182 183
16. A.S. Brett, W. Burr, J. Moloo Are gifts from pharmaceutical companies ethically problematic? A survey of physicians Arch Intern Med 163 2003 2213 2218
17. J. Dana, G. Lowenstein A social science perspective on gifts to physicians from industry JAMA 290 2003 252 255
18. N. Mizik, R. Jacobson Are physicians "easy marks"? Quantifying the effects of detailing and sampling on new prescriptions 2004 Management Science December
19. T.E. Finucane, C.E. Boult Association of funding and findings of pharmaceutical research at a meeting of a medical professional society Am J Med 117 2004 842 845
20. A.S. Relman, M. Angell America's other drug problem The New Republic 2002 27 41 December 16
21. U.E. Reinhardt An information infrastructure for the pharmaceutical market Health Aff (Millwood) 23 1 2004 07 112